EADV 2026 Late-Breaker: DecisionDx-Melanoma Data Back SLNB and Post-Surgical Use
EADV 2026 late-breaking data support the DecisionDx-Melanoma gene-expression profile test in guiding sentinel lymph node biopsy decisions and risk-aligned post-surgical management of cutaneous melano…